ClinicalTrials.gg
CompletedNCT07369726Updated Nov 2, 2026

Post-Cesarean Caffeine: Pain and Recovery

An interventional study of caffeine consumption and Decaffeinated coffee in Gastrointestinal Motility, Postoperative Pain and Psychological Well-Being, sponsored by KTO Karatay University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by KTO Karatay University · Not applicable, Interventional, and Supportive care

Updated Nov 2, 2026Now CompletedStudy completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 1,095 studies in Pain, Postoperative with a site in Turkey — 264 open to participants now, 296 under way, none of them phase 3. Pain, Postoperative · Turkey.

Enrollment
520th of 880
60 · median 70
Started
2025
with 167 others
No phase
811 of 1,095
217 open now
Registered
814th of 1,095
by date

Among the 1,095 studies in Pain, Postoperative with a site in Turkey, this one is the 520th largest by enrollment of the 880 interventional ones that give a count, is one of 168 that started in 2025, is one of 811 with no phase, and was the 814th registered.

Pain, Postoperative

5,644 studies on the registry are indexed under Pain, Postoperative; 1,229 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

264 of the 1,095 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

259 more — sign in →

All 264 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 241 (36%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.

This study: 18 Years to 35 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,095 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

Read the detailed description

In the intervention group, the goal is to initiate bowel motility by mobilizing women early in the post-cesarean period. This increased bowel motility will facilitate gas expulsion, thus minimizing pain levels. Caffeine consumption will help keep pain levels at a minimum. By minimizing pain, women will experience positive psychological well-being.

03

Conditions studied

  • Gastrointestinal Motility
  • Postoperative Pain
  • Psychological Well-Being

Keywords

  • gastrointestinal motility
  • postoperatif pain
  • Psychological Well-Being
  • Early Ambulation
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between 18 and 35 years of age,
  2. Women who underwent cesarean delivery under spinal anesthesia,
  3. Having a post-cesarean pain level of 4 or higher,
  4. Being able to understand and write Turkish and communicate effectively with researchers.

Exclusion criteria

Exclusion Criteria:

  1. Women who underwent emergency cesarean delivery,
  2. Those with pregnancy complications (preeclampsia, placenta previa, etc.),
  3. Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis),
  4. Those with sensitivity or allergy to caffeine,
  5. Those with a history of chronic pain syndrome or dependence on analgesics,
  6. Regular coffee drinkers (≥2 cups per day),
  7. Intraoperative complications such as bowel or bladder injury,

i) Those who cannot comply with the study protocol or complete the follow-up process.

Removal Criteria:

  1. Participants are excluded from the study under the following conditions:
  2. During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding),
  3. Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn,
  4. Development of severe postoperative nausea, vomiting, or intolerance to oral intake,
  5. Inability to consume or refusal to consume coffee according to the study protocol,
  6. Withdrawal of consent by the participant at any point during the study,
  7. Failure to comply with surgical procedures or loss of follow-up,
  8. Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Placebo comparator
    Control Group

    Women in the control group will receive routine intervention. They will be mobilized at 6 hours. Decaffeinated coffee will be served at 6-hour intervals.

    Dietary Supplement: Decaffeinated coffee

  • Experimental
    intervention group

    They will be mobilized at 4 hours.They will consume Turkish coffee containing caffeine every six hours.

    Dietary Supplement: caffeine consumption

Interventions

  • Dietary supplementcaffeine consumption

    The women in the intervention group will be mobilised at the 4-hour mark. The intervention group will be given caffeinated Turkish coffee at 6-hour intervals.

  • Dietary supplementDecaffeinated coffee

    The women in the control group will be mobilised at the 6-hour mark. The control group will be given decaffeinated Turkish coffee at 6-hour intervals.

06

What researchers measure

Primary outcomes

  1. Change in postoperative pain after caesarean section within 24 hours from baseline

    Pain will be assessed using a 10 cm visual analogue scale. '0' means no pain, while '10' means unbearable pain. The assessment will be carried out at the start of the study, at 6-hour intervals, and at the end.

    Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours

  2. Change in postoperative Bowel Motility after caesarean section within 24 hours from baseline

    Bowel motility will be assessed using BFI. The Bowel Function Index (BFI) is a short and practical measure used to assess constipation, particularly in patients using opioids. It consists of three questions, each scored on a scale of 0 to 100. These scores are used to measure the degree of bowel dysfunction.

    Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours

  3. Change in postoperative Psychological Well-being after caesarean section within 24 hours from baseline

    Psychological Well-being will be assessed using Psychological Well-Being Scale. Based on the score obtained: 1.00-2.99 → Low psychological resilience, 3.00-4.30 → Moderate level, 4.31-5.00 → High psychological resilience.

    Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours

07

Study locations

1 site
  • KTO Karatay University
    Konya, 42208, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Aug 2026, 8 months.

Of 2,094 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 8 months is below that.

Counting every sponsor, half of 2,107 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Nov 2, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2026
First posted
Jan 27, 2026
StartActual
Nov 25, 2025
Primary completionActual
Aug 16, 2026
CompletionActual
Oct 29, 2026was Sep 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 2, 2026
Sites
1 site added, 1 site removed
Show site
  • KTO Karatay University · Konya, Turkey (Türkiye)
Show 1 removed
  • KTO Karatay University · Konya, Turkey (Türkiye)
Nov 2, 2026
Study completion
Sep 1, 2026→Oct 29, 2026 (actual)
Nov 2, 2026
Title
Effects of Mobilization and Caffeine After Cesarean→Post-Cesarean Caffeine: Pain and Recovery
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • KTO Karatay University · Konya, Turkey (Türkiye)
    Show 1 removed
    • KTO Karatay University · Konya, Turkey (Türkiye)
    Study completion Sep 1, 2026→Oct 29, 2026 (now actual)
    Title Effects of Mobilization and Caffeine After Cesarean→Post-Cesarean Caffeine: Pain and Recovery
    + 3 other changes: verification date, responsible party and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07369726
Responsible party
Hafize Dağ Tüzmen (asst prof, KTO Karatay University) — Principal investigator
First posted
Jan 27, 2026
Start date
Nov 25, 2025
Primary completion
Aug 16, 2026
Completion
Oct 29, 2026
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion